Unraveling the Impact of KRAS Accessory Proteins on Oncogenic Signaling Pathways. [PDF]
Garg V +11 more
europepmc +1 more source
SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics. [PDF]
Eom J, Chun Y, Chang HR.
europepmc +1 more source
Targeting MET and KRAS G12C co-occurring mutation in metastatic adenoid cystic carcinoma of the trachea: a case report. [PDF]
Zhang L, Wang T, Xu Y, Ji Y, Nie K.
europepmc +1 more source
KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVM. [PDF]
Zhang D +5 more
europepmc +1 more source
Impact of Co-Mutations and Genetic Variations on Malignancy Risk in RAS-Positive Indeterminate Thyroid Nodules: an Institutional Experience. [PDF]
Wong LQ, Baloch ZW.
europepmc +1 more source
The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. [PDF]
Xing Y +6 more
europepmc +1 more source
Lymphatic Malformations With Activating KRAS Mutations Impair Lymphatic Valve Development Through Matrix Metalloproteinases. [PDF]
Mastrogiacomo DM +9 more
europepmc +1 more source
PrP<sup>C</sup>-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation. [PDF]
Lee JK, Yoon JY, Lee JY, Lee SH.
europepmc +1 more source
Regulation of Mammalian G1 Cyclin Dependent Kinase Complexes by Transforming Growth Factor-ß [PDF]
Taipale, Minna
core
Molecular Analysis Based on Fine-Needle Aspiration Washout Samples in Thyroid Nodules. [PDF]
Fakı S +10 more
europepmc +1 more source

